Literature DB >> 11454664

Endothelium-derived hyperpolarizing factor and potassium use different mechanisms to induce relaxation of human subcutaneous resistance arteries.

C A McIntyre1, C H Buckley, G C Jones, T C Sandeep, R C Andrews, A I Elliott, G A Gray, B C Williams, J A McKnight, B R Walker, P W Hadoke.   

Abstract

This investigation examined the hypothesis that release of K(+) accounts for EDHF activity by comparing relaxant responses produced by ACh and KCl in human subcutaneous resistance arteries. Resistance arteries (internal diameter 244+/-12 microm, n=48) from human subcutaneous fat biopsies were suspended in a wire myograph. Cumulative concentration-response curves were obtained for ACh (10(-9) - 3x10(-5) M) and KCl (2.5 - 25 mM) following contraction with noradrenaline (NA; 0.1 - 3 microM). ACh (E(max) 99.07+/-9.61%; -LogIC(50) 7.03+/-0.22; n=9) and KCl (E(max) 74.14+/-5.61%; -LogIC(50) 2.12+/-0.07; n=10)-induced relaxations were attenuated (P<0.0001) by removal of the endothelium (E(max) 8.21+/-5.39% and 11.56+/-8.49%, respectively; n=6 - 7). Indomethacin (10 microM) did not alter ACh-induced relaxation whereas L-NOARG (100 microM) reduced this response (E(max) 61.7+/-3.4%, P<0.0001; n=6). The combination of ChTx (50 nM) and apamin (30 nM) attenuated the L-NOARG-insensitive component of ACh-induced relaxation (E(max): 15.2+/-10.5%, P<0.002, n=6) although these arteries retained the ability to relax in response to 100 microM SIN-1 (E(max) 127.6+/-13.0%, n=3). Exposure to BaCl(2) (30 microM) and Ouabain (1 mM) did not attenuate the L-NOARG resistant component of ACh-mediated relaxation (E(max), 76.09+/-8.92, P=0.16; n=5). KCl-mediated relaxation was unaffected by L-NOARG+indomethacin (E(max); 68.1+/-5.6%, P=0.33; n=5) or the combination of L-NOARG/indomethacin/ChTx/apamin (E(max); 86.61+/-14.02%, P=0.35; n=6). In contrast, the combination of L-NOARG, indomethacin, ouabain and BaCl(2) abolished this response (E(max), 5.67+/-2.59%, P<0.0001, n=6). The characteristics of KCl-mediated relaxation differed from those of the nitric oxide/prostaglandin-independent component of the response to ACh, and were endothelium-dependent, indicating that K(+) does not act as an EDHF in human subcutaneous resistance arteries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454664      PMCID: PMC1572851          DOI: 10.1038/sj.bjp.0704143

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Influence of contractile agonists on the mechanism of endothelium-dependent relaxation in rat isolated mesenteric artery.

Authors:  F Plane; C J Garland
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

Review 3.  Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium.

Authors:  S G Taylor; A H Weston
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

4.  Potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig carotid and porcine coronary arteries.

Authors:  J F Quignard; M Félétou; C Thollon; J P Vilaine; J Duhault; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats.

Authors:  F Jiang; G J Dusting
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Evidence against potassium as an endothelium-derived hyperpolarizing factor in rat mesenteric small arteries.

Authors:  P S Lacy; G Pilkington; R Hanvesakul; H J Fish; J P Boyle; H Thurston
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

7.  Potassium does not mimic EDHF in rat mesenteric arteries.

Authors:  J M Doughty; J P Boyle; P D Langton
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

8.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice.

Authors:  T Matoba; H Shimokawa; M Nakashima; Y Hirakawa; Y Mukai; K Hirano; H Kanaide; A Takeshita
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

9.  An endogenous cannabinoid as an endothelium-derived vasorelaxant.

Authors:  M D Randall; S P Alexander; T Bennett; E A Boyd; J R Fry; S M Gardiner; P A Kemp; A I McCulloch; D A Kendall
Journal:  Biochem Biophys Res Commun       Date:  1996-12-04       Impact factor: 3.575

10.  Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives.

Authors:  C Aalkjaer; A M Heagerty; K K Petersen; J D Swales; M J Mulvany
Journal:  Circ Res       Date:  1987-08       Impact factor: 17.367

View more
  4 in total

1.  Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye.

Authors:  C Cleary; C H Buckley; E Henry; P McLoughlin; C O'Brien; P W F Hadoke
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

2.  Electrical coupling and release of K+ from endothelial cells co-mediate ACh-induced smooth muscle hyperpolarization in guinea-pig inner ear artery.

Authors:  Zhi-Gen Jiang; Alfred L Nuttall; Hui Zhao; Chun-Fu Dai; Bing-Cai Guan; Jun-Qiang Si; Yu-Qin Yang
Journal:  J Physiol       Date:  2005-02-24       Impact factor: 5.182

3.  The effect of nitric oxide synthase and cyclooxygenase inhibition on cutaneous microvascular reactivity.

Authors:  Helena Lenasi; Martin Strucl
Journal:  Eur J Appl Physiol       Date:  2008-05-31       Impact factor: 3.078

Review 4.  Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?

Authors:  Tudor M Griffith
Journal:  Br J Pharmacol       Date:  2004-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.